Home LiteratureArticle Details
PMID: 9520002 Published · ppublish English Journal Article Review

Neurologic outcome of prematurity.

Archives of neurology ·Vol. 55 ·No. 3 ·1998-03-00 ·Pages 297-300

Volpe JJ

Abstract

Brain injury in the premature infant is an extremely important problem, in part because of the large absolute number of infants affected yearly. The 2 principal brain lesions that underlie the neurological manifestations subsequently observed in premature infants are periventricular hemorrhagic infarction and periventricular leukomalacia. The emphases of this article are the neuropathological features, pathogenesis, and potential means of prevention of these 2 lesions. Recent work suggests that the ultimate goal, prevention of the lesions, is potentially achievable. Periventricular hemorrhagic infarction may be avoidable by prevention of germinal matrix-intraventricular hemorrhage, and periventricular leukomalacia by detection of impaired cerebrovascular autoregulation, prevention of impaired cerebral blood flow, and interruption of the cascade to oligodendroglial cell death by such agents as free radical scavengers.

MeSH Terms
Brain/growth & development,physiopathology Cerebral Infarction/physiopathology,prevention & control Humans Infant, Newborn Infant, Premature/growth & development Leukomalacia, Periventricular/physiopathology,prevention & control
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Volpe J J
Harvard Medical School and Children's Hospital, Boston, Mass 02115, USA. [email protected]
Article Info
Journal
Archives of neurology
Abbr.
Arch Neurol
ISSN
0003-9942
Published
1998-03-00
Pages
297-300
Language
English
Region
United States
NLM ID
0372436
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]